Your search matched 11 results
Policymakers continue their focus on drug pricing and may also have eyes for changes to the Orphan Drug Act.
What do vacationers on a cruise ship in St.
SCOTUS is weighing its options on a number of healthcare cases; using social activism to tip the scales for your brand reputation; and crowdfunding for what?
Climate change is named a top 10 health threat and we’ve broken down the conundrum for pharma companies regarding activating on the issue.
The Week That Was: ... | Blog
Our favorite #healthpolicyvalentines, new FDA guidance regarding complex generics and what you need to know now regarding data security from pharma and patient perspectives.
As drug pricing continues to be under the microscope, it’s a tough environment for drug makers.
Winter is coming… in May.
You think you’re busy?
Missed BIO 2019?
This week's edition of The Week That Was details how health and medical groups are taking action to address the “greatest public health challenge of the 21st century” and what you need to know from a busy week in healthcare policy.